Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,065 signal articles · 239 in last 24h · 119,553 total before filter · latest 1h ago
239last 24h
1471last 7d
249● bullish (7d)
157● bearish (7d)
205publishers
AllMacro282Earnings562M&A105Regulatory20Product13Analyst22
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?
Insider Monkey6d agoneutral
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?

On July 20, Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Incyte Corporation (NASDAQ:INCY) announced a global collaboration and licensing deal to develop a subcutaneous formulation of Incyte’s INCA033989. The first-in-class monoclonal antibody targets mutant calreticulin (mutCALR)-expressing myeloproliferative neoplasms. By utilizing Halozyme’s proprietary ENHANZE drug delivery technology, INCY aims to create a more convenient dosing regimen for patients. […]

FitLife Brands Q2 Earnings Call Highlights
MarketBeat6d agoneutral
FitLife Brands Q2 Earnings Call Highlights

FitLife Brands (NASDAQ:FTLF) reported second-quarter 2026 revenue of $26.5 million, up 65% from a year earlier, as the company’s acquisition of Irwin Naturals more than offset declines in its Legacy FitLife business. Net income rose to $2.0 million from $1.7 million in the prior-year quarter, while

DLocal Q2 Earnings Call Highlights
MarketBeat6d agoneutral
DLocal Q2 Earnings Call Highlights

DLocal (NASDAQ:DLO) reported second-quarter 2026 total payment volume of $17.7 billion, up 92% from a year earlier, as growth in ride-hailing, travel, remittances, e-commerce and other verticals drove record volume and gross profit. Chief Executive Officer Pedro Arnt said the company processed more

Bank of America reveals Rocket Lab stock outlook after earnings
TheStreet6d agoneutral
Bank of America reveals Rocket Lab stock outlook after earnings

Rocket Lab’s second-quarter results gave Bank of America another reason to stay bullish on the space company, even as one part of the business came in lighter than Wall Street expected. Bank of America reiterated its Buy rating and $115 price objective on Rocket Lab (RKLB) after earnings, analyst ...

Use This Zacks Tool to Find Strong Cloud Stocks
Zacks6d agoneutral
Use This Zacks Tool to Find Strong Cloud Stocks

Cloud computing refers to the on-demand seamless access of computing resources such as servers, storage, databases, networking, software, analytics, and intelligence over the Internet (the cloud) on a pay-per-use pricing model.

AI Data Centers Are Running Out of Water. This $6 Stock Has a Fix
Insider Monkey6d agoneutral
AI Data Centers Are Running Out of Water. This $6 Stock Has a Fix

Major AI stocks are getting expensive and everyday investors are in search of low-priced names that have the potential to return huge profits in the long term. To find where smart retail investors are putting their money, we scoured Reddit’s investing communities and zeroed in on low-priced stocks with real growth potential. One name kept […]

Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
Insider Monkey6d agoneutral
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?

On July 23, Genmab A/S (NASDAQ:GMAB) and AbbVie Inc. (NYSE:ABBV) clarified a key clinical setback regarding their jointly developed T-cell engaging bispecific antibody, epcoritamab (DuoBody-CD3xCD20). The Phase 3 EPCORE DLBCL-1 study evaluated epcoritamab monotherapy against investigator’s choice of chemoimmunotherapy in transplant-ineligible adults with relapsed/refractory diffuse large B-cell lymphoma. The clarification confirmed that in the United […]

RKLB Q2 Deep Dive: Iridium Acquisition, Neutron Progress, and Margin Pressures Shape Outlook
StockStory6d agoneutral
RKLB Q2 Deep Dive: Iridium Acquisition, Neutron Progress, and Margin Pressures Shape Outlook

Aerospace and defense company Rocket Lab (NASDAQ:RKLB) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 62% year on year to $234.1 million. On top of that, next quarter’s revenue guidance ($257.5 million at the midpoint) was surprisingly good and 7% above what analysts were expecting. Its non-GAAP loss of $0.02 per share was 64.4% above analysts’ consensus estimates.

Delta Air Lines has a reliability problem that may get worse
TheStreet6d agoneutral
Delta Air Lines has a reliability problem that may get worse

If you fly regularly, you understand that delays happen, and as a frequent flyer myself, I'll say that they're forgivable, as long as the airline gets me to my intended destination eventually. Airlines, however, have been bragging about their ability to get you there on time. Cirium has published ...

Coca-Cola’s Raised Guidance And Margin Gains Might Change The Case For Investing In Coca-Cola (KO)
Simply Wall St.6d agoneutral
Coca-Cola’s Raised Guidance And Margin Gains Might Change The Case For Investing In Coca-Cola (KO)

Coca-Cola recently posted a strong second quarter, with healthy global demand, improving margins, broad-based volume growth, and management raising full-year revenue and earnings guidance. This upgraded outlook, alongside ongoing market-share gains and disciplined cost control, has reinforced investor confidence in the company’s ability to sustain its operating performance. We’ll now explore how Coca-Cola’s raised full-year guidance and margin improvement shape the company’s broader...

S&P 500 notches record-high close as rate-hike worries ease
Reuters Videos6d agoneutralVIDEO
S&P 500 notches record-high close as rate-hike worries ease

<body><p>VIDEO SHOWS: N/A</p><p>STORY: Wall Street's main indexes ended higher on Thursday, with the Dow ticking up marginally, the S&P 500 adding nearly two-thirds of a percent to close at a record high, and the tech-heavy Nasdaq climbing more than eight-tenths of a percent.</p><p>Several chip stocks led the way, with shares of Sandisk surging nearly 14% after the memory chip maker said it expects revenue to grow at a mid-to-high-teens percentage rate from fiscal years 2028 to 2030, encouraged by strong demand amid rapid AI infrastructure buildout.&nbsp;</p><p>On the flip side, shares of Cisco fell more than 8% despite the AI infrastructure company a day earlier forecasting fiscal 2027 revenue above Wall Street expectations.</p><p>Eric Diton is president and managing director of The Wealth Alliance.</p><p>"Sandisk up double digits with just great numbers, great expectations for future revenue for margins, which by the way is what took Cisco down today. Cisco beat on earnings, beat on revenue, but the street focused on a little over a 2% drop in margin, and they beat up the stock pretty well. But generally speaking, the Nasdaq's having a great day, up roughly three quarters of a percent, led by the chips."</p><p>Elsewhere in the market, shares of Netflix climbed more than 5% after billionaire investor Bill Ackman unveiled a new holding in the streaming company as part of Pershing Square's biggest portfolio overhaul in years.</p><p>And shares of Tapestry plunged more than 16% after the Coach owner forecast muted annual revenue growth.</p><p>Meanwhile, fresh data showed U.S. producer prices were unchanged in July, while the number of Americans filing claims for unemployment benefits increased moderately last week, pointing to a stable jobs market.</p><p>Traders are pricing in a more than 60% chance that the Federal Reserve will keep interest rates unchanged at its meeting next month, according to CME's FedWatch tool.</p></body>

DLocal (DLO) Stock Could Be Cheap on Fair Value but Pricey on Earnings
Simply Wall St.6d agoneutral
DLocal (DLO) Stock Could Be Cheap on Fair Value but Pricey on Earnings

DLocal’s share price is still down 74.8% over the past five years, yet the latest valuation work paints a split picture, with the intrinsic value estimate pointing to upside while traditional earnings based multiples lean the other way. The stock has declined 74.8% over five years, which means long term holders have seen a heavy drawdown that now frames any debate about upside. Strong growth in payment volumes and profits can support higher earnings expectations. However, any setback in...

FuelCell Energy (FCEL) Pushes Carbon Capture, Is The Stock Fully Valued?
Simply Wall St.6d agoneutral
FuelCell Energy (FCEL) Pushes Carbon Capture, Is The Stock Fully Valued?

Recent attention on FuelCell Energy (FCEL) centers on its carbon capture platform, which captures emissions from existing fossil fuel plants while generating extra electricity. The platform uses a modular setup that can scale across different project sizes. See our latest analysis for FuelCell Energy. The recent focus on FuelCell Energy's carbon capture platform comes alongside sharp share price moves, with the 1 year total shareholder return of very large magnitude and the 3 year and 5 year...

Marvell (MRVL) Stock Trades At A Premium After A 290% Run
Simply Wall St.6d agoneutral
Marvell (MRVL) Stock Trades At A Premium After A 290% Run

Marvell Technology stock has delivered a very strong 289.6% return over the past three years, yet current valuation checks suggest the shares are priced at a premium rather than standing out as a clear bargain. The 289.6% three year return highlights how strongly sentiment has shifted in favor of Marvell Technology and raises the bar for what future fundamentals may need to justify. Investor focus on Marvell’s role in AI data center and memory infrastructure can support high expectations,...